Vitamin D Market (By Analog: Vitamin D2, Vitamin D3; By Form: Dry, Liquid; By End Users: Adults, Pregnant Women, Children; By Application: Feed & Pet Food, Pharma, Functional Food, Personal Care) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
The global vitamin D market size was USD 792.80 million in 2023, accounted for USD 841.80 million in 2024, and is expected to reach around USD 1,533.32 million by 2034, expanding at a CAGR of 6.2% from 2024 to 2034. Rising cases of conditions due to vitamin D deficiency, heightened public awareness about maintaining a balanced diet, and increased demand for vitamin D in the food and beverage industry are some more notable factors driving the growth of the market.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
Vitamin D is a steroid essential for maintaining normal metabolic functions in the human body. It plays a crucial role in promoting the absorption and metabolism of calcium and phosphorus in the intestines. Deficiency in this nutrient profile can result in bone deformities in children (rickets) and bone weakness in adults. It is vital for average growth and development, protects against muscle weakness, regulates heart functions, and is essential for maintaining healthy bones and teeth.
Vitamin D is found in eggs, fish, and dairy products and is also produced in the human skin through sun exposure. However, a large portion of the global population is experiencing a significant lack of vitamin D, primarily due to imbalanced diets and insufficient exposure to sunlight. Government organizations worldwide are taking necessary steps to address this deficiency.
Report Coverage | Details |
Growth Rate from 2024 to 2034 | CAGR of 6.2% |
Global Market Size in 2023 | USD 792.80 Million |
Global Market Size in 2024 | USD 841.80 Million |
Global Market Size by 2034 | USD 1,533.32 Million |
Largest Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | By Analog, By Form, By End Users, and By Application |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Shifting consumers' preference toward fortified food
The increasing consumer preference for fortified food and growing awareness of the importance of assimilating fortified food into regular meals and diets are major drivers of the vitamin D market globally. Consumers seek nutrition-rich food and options that provide essential ingredients for better health and disease prevention. Key market players like BASF SE, Xiamen Kingdomway Vitamin Corporation, and Alliance Nutrition Inc. focus on developing improved and enhanced vitamin D-enriched products to meet the rising consumer demand worldwide.
Prevalence of chronic disorders among the majority of the population
The rise in chronic disorders, particularly rickets, a condition caused by vitamin D deficiency and poor dietary habits, is anticipated to aid the growth of the vitamin D market significantly. Urban residents, often spending prolonged hours in workplaces, are at a higher risk of vitamin D deficiency. As a result, there is an increasing demand for various vitamin D supplements and components, particularly in urban regions where the urban lifestyle may contribute to a lack of sunlight, a natural source of vitamin D.
Side effects of vitamin D supplements
Long-term, excessive doses of vitamin D3 can lead to various health issues, including elevated blood and calcium levels and kidney failure. Common side effects include Headaches, nausea, loss of appetite, constipation, diarrhea, and vomiting. The vitamin D market faces challenges such as the high initial investments required for advanced manufacturing machinery, filling, and packaging to prevent contaminations, which may impact revenue growth. Limited natural food sources containing vitamin D contribute to the risk of deficiency among consumers. Additionally, vitamin D and other vitamins are experiencing raw material shortages, leading to price increases and a significant barrier to market growth.
Government support and frequent product launches by market players
One primary driver of the vitamin D market is the widespread vitamin D deficiency across the global population. The market is anticipated to grow due to increasing awareness of its benefits and the rising prevalence of bone-related disorders like rheumatoid arthritis. Factors such as the growing incidence of osteomalacia in adults and government regulations promoting vitamin D3 fortification in food contribute to the market's expansion.
Government agencies and key market players focus on enhancing vitamin D-enriched products to meet rising consumer demand worldwide. Support from organizations like the Food and Agricultural Organization (FAO) and the World Health Organization (WHO) highlights the importance of food fortification in addressing malnutrition, especially in developing countries.
The dry segment led the vitamin D market in 2023. The increased preference for the dry form of vitamin D is primarily due to its benefits, such as stability, a long shelf life, ease of handling, transportation, and storage. Additionally, the high solubility of vitamin D has led to a growing demand for it in powder and capsule forms. Beadlets and crystalline forms are also part of this segment, finding use in various industries like medicine, animal feed, and cosmetics. The potency and effectiveness of dry forms make them suitable for supplements, contributing to the growth of the dry segment of the market.
During the forecast period, the liquid segment is anticipated to grow at a notable rate in the vitamin D market, driven by its growing application in the food and beverage industry and the pharmaceutical sector. This form is commonly used in food supplements to enhance immunity, support cardiovascular health, and fortify bones.
The pharmaceutical segment dominated the global vitamin D market share in 2023. This was driven by the increased use of plant and animal-based products as sources of vitamin D for various medicinal formulations. Additionally, the significant rise in the number of people experiencing vitamin D deficiency worldwide is anticipated to boost the segment's growth further in the coming years.
The feed & pet food segment is the fastest-growing market over the forecast period. Pet food is a specialized type of food formulated to meet the nutritional needs of domesticated animals. It typically includes meat, meat by-products, cereals, grains, vitamins, and minerals. These products are sold in pet stores and supermarkets as pet food is designed for specific animals, such as dogs or cats. It's important to note that the meat used in pet food is often a byproduct of the human food industry and may not be considered "human grade." moreover, innovative product launches by market players fuel the segment growth.
The adult segment dominated the global vitamin D market in 2023 with the largest share. The increasing prevalence of diseases, such as osteomalacia, osteopenia, and osteoporosis, in individuals aged 50 and above due to severe vitamin D deficiency is a significant factor driving the demand for the product in this segment. The high content of vitamins D2 and D3 is utilized to address weaknesses in the human body, promoting healthy bones and teeth, leading to higher adoption of the product among adult consumers worldwide.
The pregnant women segment is anticipated to grow at a significant rate in the vitamin D market. The active form of vitamin D is crucial for facilitating calcium absorption from the gut, supporting normal bone mineralization, and promoting growth. In cases of severe maternal vitamin D deficiency during pregnancy, there have been associations with biochemical indicators of disrupted skeletal balance, congenital rickets, and fractures in newborns.
Asia Pacific held the largest share of the vitamin D market in 2023, and it is anticipated that it will maintain this dominance throughout the forecast period. The market’s leading position is supported by the easy availability of raw materials, such as milk, and the consistent rise in consumer disposable income. Additionally, the high prevalence of vitamin D deficiency among people in the region contributes to the market's expansion. Malaysians exhibit a high incidence of vitamin D deficiency due to the increased prevalence of various non-communicable diseases like diabetes mellitus, as reported by the National Health Survey. The recent launches and acquisitions also serve the market.
North America is expected to experience significant growth, driven by increasing consumer awareness of the health benefits associated with vitamin D consumption. Additionally, many Canadians face a deficiency in vitamin D levels due to its insufficient presence in their food. To address this deficiency, several key players are introducing new supplements that aim to mitigate vitamin D deficiency and reduce the risk of osteoporosis among Canadians.
Segments Covered in the Report
By Analog
By Form
By End Users
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Vitamin D Market
5.1. COVID-19 Landscape: Vitamin D Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Vitamin D Market, By Analog
8.1. Vitamin D Market Revenue and Volume Forecast, by Analog, 2024-2034
8.1.1. Vitamin D2
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Vitamin D3
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Vitamin D Market, By Form
9.1. Vitamin D Market Revenue and Volume Forecast, by Form, 2024-2034
9.1.1. Dry
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Liquid
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Vitamin D Market, By End Users
10.1. Vitamin D Market Revenue and Volume Forecast, by End Users, 2024-2034
10.1.1. Adults
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Pregnant Women
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Children
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Vitamin D Market, By Application
11.1. Vitamin D Market Revenue and Volume Forecast, by Application, 2024-2034
11.1.1. Feed & Pet Food
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Pharma
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Functional Food
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1.4. Personal Care
11.1.4.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 12. Global Vitamin D Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Analog (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Form (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)
Chapter 13. Company Profiles
13.1. BASF SE
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Tech Pharmacal
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Divi's Nutraceuticals
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Synthesia, a.s.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PHW Group Lohmann & Co.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sichuan Neijiang Huixin Pharmaceutical Co Ltd
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Fermenta Biotech Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dishman Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Abbott Laboratories
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. DSM
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client